Ovid Therapeutics Inc.
Pharmaceutical company · New York, United States · Nasdaq: OVID
Ovid Therapeutics Inc. is a pharmaceutical company headquartered in New York, United States. Its earliest recorded incorporation is in 2014. Its shares trade on Nasdaq under the ticker OVID. It has reported private securities offerings to the US SEC, most recently $26 million sold in a notice filed in 2017.
Ovid Therapeutics at a glance
What does Ovid Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $25.9 million sold (2017).
Frequently asked questions about Ovid Therapeutics
Where is Ovid Therapeutics headquartered?
Ovid Therapeutics Inc. is headquartered in New York, United States.
What does Ovid Therapeutics do?
Ovid Therapeutics Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Ovid Therapeutics a public company?
Yes. Ovid Therapeutics Inc. trades on Nasdaq under the ticker OVID.
When was Ovid Therapeutics founded?
The earliest incorporation on record for Ovid Therapeutics Inc. is in 2014, according to public company registers.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.